HAEMATO PHARM GmbH
HAEMATO MED GmbH
HAEMATO AG
News
According to the preliminary IFRS financial statements for the 2020 financial year, HAEMATO AG increased its revenue by 20.5 % to EUR 238.3 million and increased EBITDA by 74.8 % to EUR 3.3 million
Corporate News of HAEMATO AG: According to the preliminary IFRS financial statements for the 2020 financial year, HAEMATO AG increased its revenue by 20.5 % to EUR 238.3 million and increased EBITDA by 74.8 % to EUR 3.3 million. In the 2020 financial year, HAEMATO AG,...
HAEMATO AG successfully completes capital increase
HAEMATO AG (ISIN: DE000A289VV1, WKN: A289VV) has successfully completed the capital increase which was announced on March 24, 2021. The capital increase was oversubscribed. The Company increased its share capital by € 475,391.00 to € 5,229,307.00 by issuing a total of...
HAEMATO AG plans cash capital increase to finance private label business
HAEMATO AG plans cash capital increase to finance private label businessHAEMATO AG resolves to carry out a cash capital increase using the Authorized Capital 2018 with exclusion of subscription rights in the amount of up to 10% of the share capital to finance the...

Publications
Contact
Do you have any questions or suggestions? We look forward to hearing from you.
HAEMATO AG
HAEMATO AG
Lilienthalstraße 5c
12529 Schönefeld
Germany
Phone: +49-30 897 30 86 70
Telefax: +49-30 897 30 86 79
E-Mail: info@haemato.ag
HAEMATO Group